Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Nanobiotix S.A.

Present final phase I results for Study 103

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
8 Jan 2021
Due
31 Mar 2021
Delivered
January 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“1Q 2021 – Final presentation of phase I results”

What we found

Evidence strength A What the grades mean

The company presented final Phase I results for Study 103 in January 2021 at the ASCO-GI annual meeting, which falls within the first quarter of 2021.

  • A
    Nanobiotix S.A. 20-F filed 2021-04-07 Regulatory filing · published 7 Apr 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 73017e60e2f0
    “Final data with respect to the Phase I part of Study 103 was presented in October 2020 at the annual meeting of the American Society for Radiation Oncology (ASTRO) and in January 2021 at the annual meeting of the Gastrointestinal Cancers Symposium (ASCO-GI).” ✓ confirmed on the page

Market reaction: the shares moved +4.6% against the S&P 500 over the three sessions around the disclosure (6 Apr 2021 to 9 Apr 2021). What this measures

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Present
Deliverable
Study 103 phase I results
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Nanobiotix S.A.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-NBTX-021367 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.